Disclosure of Invention
Based on the above problems, the present invention provides a bacteria preservation medium and a method for preparing the same, which can improve the activity in the preservation of strains. The specific technical scheme is as follows:
a bacteria preservation medium comprises the following components:
contains, in 1000 ml: 8-13g of beef extract, 2-6g of peptone, 0.2-0.5g of bile salt, 0.2-0.3g of aluminum potassium sulfate, 2-5g of malt extract powder, 3-7g of yeast extract powder, 0.3-0.6g of sodium chloride, 5-10g of agar, 0.2-0.5g of soluble iron salt, 0.01-0.05g of calcium supplement, 0.02-0.05g of D-cycloserine, 0.001-0.004g of maozolone, 10.01-0.02g of vitamin K, 0.1-0.3g of complex protein phosphopeptide, 3-5g of glucose, 1-2.5g of lanthanum nitrate, 3-5g of erythritol, 18-23ml of glycerol, 0.1-0.2mg of warfarin sodium tablet, 8-12mg of isoniazide and 75-85ml of aseptic defibrinated sheep blood.
Preferably, the bacteria preservation medium comprises the following components:
in 1000 ml: 10g of beef extract, 5g of peptone, 0.3g of bile salt, 0.25g of potassium aluminum sulfate, 4g of malt extract powder, 5g of yeast extract powder, 0.5g of sodium chloride, 8g of agar, 0.3g of ferric citrate, 0.03g of calcium lactate, 0.03g of D-cycloserine, 0.003g of maozolone, 10.01g of vitamin K, 0.1g of complexing protein phosphopeptide, 5g of glucose, 2g of lanthanum nitrate, 4g of erythritol, 20ml of glycerol, 0.1mg of warfarin sodium tablets, 10mg of isoniazide, 80ml of sterile defibrinated sheep blood, and distilled water added to 1000 ml.
Specifically, the soluble ferric salt is ferric ammonium citrate.
Specifically, the calcium supplement is calcium lactate.
The preparation method of the bacteria preservation culture medium comprises the following steps:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 50-60 ℃ to dissolve all substances;
(3) sterilizing the above solutions, and subpackaging in culture vessels for cooling.
Specifically, the sterilization condition is that the temperature is 130-150 ℃ and the time is 3-5 h.
Specifically, the culture vessel is any one of a test tube or a culture vessel.
Specifically, the refrigeration temperature is 2-4 ℃.
Compared with the prior art, the invention has the beneficial effects that:
the formula of the invention contains peptone, bile salt, potassium aluminum sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, ferric ammonia, calcium lactate, D-cycloserine, maozolone, vitamins, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol and distilled water, and the nutrient substances are rich and comprehensive. The contained components of ferric citrate, calcium lactate, complex protein phosphopeptide, glucose, vitamin, lanthanum nitrate and the like can ensure the survival of strains. Wherein, the bile salt, D-cycloserine, maozolone and other substances have the function of inhibiting the growth of bacteria and are beneficial to the long-term survival of the bacteria. The warfarin sodium tablet and isoniazid can reduce the metabolism of bacteria and inhibit the growth of bacteria. Erythritol, glycerol and other substances have the moisturizing effect and meet the requirement of sufficient water content of the culture medium. The agar powder has low content, is semisolid in culture medium, and is beneficial for bacteria preservation. When the culture medium is used for preserving bacteria, the growth period of the bacteria is slow, mixed bacteria can not grow, the activity of the bacteria can be kept and the bacteria can not die easily, and even if the preservation environment is changed greatly, the culture medium can still ensure the effectiveness of the strains. The culture medium has simple preparation equipment, low cost and high practical value.
Detailed Description
Example 1:
a bacteria preservation medium comprises the following components:
contains, in 1000 ml: 8g of beef extract, 2g of peptone, 0.2g of bile salt, 0.2g of potassium aluminum sulfate, 2g of malt extract powder, 3g of yeast extract powder, 0.3g of sodium chloride, 5g of agar, 0.2g of soluble ferric salt, 0.01g of calcium supplement, 0.02g of D-cycloserine, 0.001g of maozolone, 10.01g of vitamin K, 0.1g of complex protein phosphopeptide, 3g of glucose, 1g of lanthanum nitrate, 3g of erythritol, 18ml of glycerol, 0.1mg of warfarin sodium tablets, 8mg of isoniazide and 75ml of sterile defibrinated sheep blood; the soluble ferric salt is ferric ammonium citrate; the calcium supplement is calcium lactate.
The bacteria preservation medium described in this example was prepared as follows:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 50 ℃ to dissolve all substances;
(3) sterilizing the solution, and subpackaging in culture vessels for cooling for later use; the sterilization condition is that the temperature is 130 ℃ and the time is 3 h; the culture vessel is a test tube; the refrigeration temperature is 2 ℃.
Example 2
A bacteria preservation medium comprises the following components:
in 1000 ml: 10g of beef extract, 5g of peptone, 0.3g of bile salt, 0.25g of potassium aluminum sulfate, 4g of malt extract powder, 5g of yeast extract powder, 0.5g of sodium chloride, 8g of agar, 0.3g of ferric citrate, 0.03g of calcium lactate, 0.03g of D-cycloserine, 0.003g of maozolone, 10.01g of vitamin K, 0.1g of complexing protein phosphopeptide, 5g of glucose, 2g of lanthanum nitrate, 4g of erythritol, 20ml of glycerol, 0.1mg of warfarin sodium tablets, 10mg of isoniazide, 80ml of sterile defibrinated sheep blood, and distilled water added to 1000 ml.
The bacteria preservation medium described in this example was prepared as follows:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 55 ℃ to dissolve all substances;
(3) sterilizing the solution, and subpackaging in culture vessels for cooling for later use; the sterilization condition is that the temperature is 140 ℃ and the time is 4 hours; the culture vessel is a test tube; the refrigeration temperature is 3 ℃.
Example 3
A bacteria preservation medium comprises the following components:
contains, in 1000 ml: 13g of beef extract, 6g of peptone, 0.5g of bile salt, 0.3g of aluminum potassium sulfate, 5g of malt extract powder, 7g of yeast extract powder, 0.6g of sodium chloride, 10g of agar, 0.5g of soluble ferric salt, 0.05g of calcium supplement, 0.05g of D-cycloserine, 0.004g of maozolone, 10.02g of vitamin, 0.3g of complexing protein phosphopeptide, 5g of glucose, 2.5g of lanthanum nitrate, 5g of erythritol, 23ml of glycerol, 0.2mg of warfarin sodium tablets, 12mg of isoniazide and 85ml of sterile defibrinated sheep blood; the soluble ferric salt is ferric ammonium citrate; the calcium supplement is calcium lactate.
The bacteria preservation medium described in this example was prepared as follows:
(1) according to the raw material proportion, taking beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride, agar, soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazid and sterile defibrinated sheep blood for later use;
(2) uniformly mixing beef extract, peptone, bile salt, aluminum potassium sulfate, malt extract powder, yeast extract powder, sodium chloride and agar, pouring soluble iron salt, a calcium supplement, D-cycloserine, maozolone, vitamin K1, complex protein phosphopeptide, glucose, lanthanum nitrate, erythritol, glycerol, warfarin sodium tablets, isoniazide and sterile defibrinated sheep blood, adding distilled water to 1000ml, and heating to 60 ℃ to dissolve all substances;
(3) sterilizing the solution, and subpackaging in culture vessels for cooling for later use; the sterilization condition is that the temperature is 150 ℃ and the time is 5 h; the culture vessel is a culture vessel; the refrigeration temperature was 4 ℃.
To verify the inventive scheme, the following comparative examples were set up:
| comparative example 1 | The difference from example 1 is that maozolone is not used in the manufacturing raw material; |
| comparative example 2 | The difference from the embodiment 1 is that the ferric ammonium citrate is not used in the preparation raw material; |
| comparative example 3 | The difference from example 1 is that lanthanum nitrate is not used in the preparation raw material; |
| comparative example 4 | The difference from example 1 is that D-cycloserine was not used in the starting material; |
| comparative example 5 | The difference from example 1 is that isoniazid was not used as a starting material. |
Test examples
Respectively preparing culture media according to examples 1-3 and comparative examples 1-5, pouring the culture media into culture dishes in an aseptic environment, adding 2ml of bacterial liquid into each culture dish, and storing in a refrigerator at minus 50 ℃; the test strains are respectively staphylococcus aureus, escherichia coli and proteus, the culture dish inoculated by each bacterium is independently preserved, and the recovery is carried out after 5 months and 10 months of preservation, and the activity of the bacteria is counted.
When the strains are revived, hot water with the temperature of 35 ℃ is selected for heating and unfreezing in water bath, the most suitable culture medium of each strain is selected for culture, and the revival quantity is counted.
The test results are shown in the following table.
As can be seen from the table, the bacteria preservation effect of the bacteria preservation medium of the embodiment 1-3 is excellent, the preservation survival rate of the staphylococcus aureus, the escherichia coli and the proteus can reach 100% within five months, the preservation time is prolonged to 1 month, the survival rate of the staphylococcus aureus can reach more than 98.94%, the survival rate of the escherichia coli can reach more than 98.41%, and the survival rate of the proteus can reach more than 98.31%, so that the remarkable effect of the bacteria preservation effect of the medium is achieved.
The above refrigeration operation of the bacteria was repeated in a refrigerator at a refrigeration temperature of-30 ℃ to count the survival rates of the bacteria after 5 months and 10 months of refrigeration.
The test results are shown in the following table.
As can be seen from the table, when the bacteria were preserved using the culture media of examples 1 to 3 of the present invention, the survival rate of Staphylococcus aureus was more than 99.50%, the survival rate of Escherichia coli was more than 99.70%, and the survival rate of Proteus bacteria was more than 99.65% in the 5-month preservation; the survival rate of staphylococcus aureus exceeds 96.50 percent, the survival rate of escherichia coli exceeds 96.81 percent and the survival rate of proteus bacteria exceeds 96.62 percent in the preservation of 10 months. The culture medium prepared by the method can ensure the activity of the strains even under the condition that the strain preservation temperature is increased, and if the preservation equipment has problems in actual use and causes great change of the environment, the method can still ensure the effectiveness of the strains, and the practical value is obvious.